Table 2

Comparison of aciclovir susceptibilities in isolated VZV between before and during the oral aciclovir treatment

Patient No		Before aciclovir				During aciclovir
Patient No		EC₅₀ 2-150	EC₈₀ 2-150			EC₅₀ 2-150	EC₈₀ 2-150
1	1.27 (0.15)	2.33 (0.78)		1.32 (0.26)	2.03 (0.51)
2	1.45 (0.15)	2.48 (0.81)		1.30 (0.09)	2.30 (0.64)
3	1.57 (0.47)	2.57 (1.01)		1.47 (0.29)	2.58 (0.90)
4	1.55 (0.22)	3.55 (0.22)		1.41 (0.32)	2.67 (0.69)
5	1.24 (0.17)	3.00 (0.53)		1.42 (0.37)	3.28 (0.63)
6	1.46 (0.26)	2.72 (0.79)		1.26 (0.16)	2.03 (0.59)
Mean	1.42 (0.14)	2.78 (0.44)		1.36 (0.08)	2.48 (0.47)

Both EC₅₀ and EC₈₀ before vduring aciclovir were not significant.
↵2-150 μg/ml.